diazoxide has been researched along with rottlerin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ashraf, M; Ayub, A; Kudo, M; Wang, Y; Xu, M | 1 |
Dreixler, JC; Roth, S; Shaikh, AR; Shen, Y; Shenoy, SK | 1 |
3 other study(ies) available for diazoxide and rottlerin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
Topics: Acetophenones; Active Transport, Cell Nucleus; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Benzopyrans; Blood Flow Velocity; Blood Pressure; Cell Nucleus; Decanoic Acids; Diazoxide; Enzyme Inhibitors; Heart Ventricles; Hydroxy Acids; Ischemia; Ischemic Preconditioning, Myocardial; Isoenzymes; L-Lactate Dehydrogenase; Mice; Mice, Knockout; Mitochondria; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Protein Kinase C-delta; Reperfusion Injury; Signal Transduction; Time Factors; Transcription Factor RelA; Up-Regulation | 2001 |
Protein kinase C subtypes and retinal ischemic preconditioning.
Topics: Acetophenones; Animals; Apoptosis; Benzopyrans; Blotting, Western; Cells, Cultured; Diazoxide; Electroretinography; Enzyme Inhibitors; In Situ Nick-End Labeling; Ischemic Preconditioning; Isoenzymes; Potassium Channels; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Diseases; Retinal Vessels; RNA, Small Interfering; Vasodilator Agents | 2008 |